Provided by Tiger Trade Technology Pte. Ltd.

Vincera Pharma, Inc.

0.0120
-0.0003-2.44%
Volume:1.00K
Turnover:12.00
Market Cap:62.81K
PE:0.00
High:0.0120
Open:0.0120
Low:0.0120
Close:0.0123
52wk High:10.37
52wk Low:0.0002
Shares:5.23M
Float Shares:4.94M
Volume Ratio:0.51
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.9799
EPS(LYR):-15.8451
ROE:-3136.43%
ROA:-197.53%
PB:0.03
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Vincera Pharma, Inc.
Exchange:
PINK
Establishment Date:
2019
Employees:
13
Office Location:
1825 S. Grant Street,San Mateo,California,United States
Zip Code:
94402
Fax:
- -
Introduction:
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.